NCT00952094View on ClinicalTrials.gov

Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

June 30, 2009

Conditions
Healthy
Interventions
DRUG

KRN1493

KRN1493 25mg tablet 2,3 or 4 tablets single oral administration

Trial Locations (1)

Unknown

Seoul National University Hospital Clinical Trial Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Jeil-Kirin Pharmaceutical Inc.

INDUSTRY

collaborator

Kyowa Hakko Kirin Pharma, Inc.

INDUSTRY

lead

Seoul National University Hospital

OTHER

NCT00952094 - Pharmacokinetic, Pharmacodynamic and Safety Evaluation After Single Oral Administration of KRN1493 | Biotech Hunter | Biotech Hunter